Patent details

EP1799269 Title: OLIGORIBONUCLEOTIDES AND METHODS OF USE THEREOF FOR TREATMENT OF ALOPECIA, ACUTE RENAL FAILURE AND OTHER DISEASES

Basic Information

Publication number:
EP1799269
PCT Application Number:
PCT/IL/2005/001035
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057884926
PCT Publication Number:
WO/2006/035434
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
OLIGORIBONUCLEOTIDES AND METHODS OF USE THEREOF FOR TREATMENT OF ALOPECIA, ACUTE RENAL FAILURE AND OTHER DISEASES
French Title of Invention:
OLIGORIBONUCLÉOTIDES ET PROCÉDÉS D'UTILISATION ASSOCIÉS POUR LE TRAITEMENT DE L'ALOPÉCIE, DES INSUFFISANCES RÉNALES AIGUËS ET D'AUTRES MALADIES
German Title of Invention:
OLIGORIBONUKLEOTIDE UND ANWENDUNGSVERFAHREN DAFÜR ZUR BEHANDLUNG VON ALOPEZIE, AKUTER NIERENINSUFFIZIENZ UND ANDEREN ERKRANKUNGEN
SPC Number:

Dates

Filing date:
27/09/2005
Grant date:
07/09/2016
EP Publication Date:
07/09/2016
PCT Publication Date:
06/04/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/06/2007
EP B1 Publication Date:
07/09/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
27/09/2022
Expiration date:
27/09/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
27/09/2005
 
 

Name:
Quark Pharmaceuticals Inc.
Address:
6501 Dumbarton Circle, Fremont, California 94555, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
21/09/2016
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
EHRLICH Shai
Address:
United States (US)

2

Name:
FEINSTEIN Elena
Address:
Israel (IL)

3

Name:
ZURR Daniel
Address:
Israel (IL)

Priority

1

Priority Number:
613991 P
Priority Date:
28/09/2004
Priority Country:
United States (US)

2

Priority Number:
658196 P
Priority Date:
02/03/2005
Priority Country:
United States (US)

3

Priority Number:
703020 P
Priority Date:
26/07/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
C12N 15/113;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
21/09/2021
Last Annual Fee Paid Number:
17
Last Annual Fee Paid Amount:
246 Euro
Payer:
DENNEMEYER & CO
Filing date Document type Number of pages